Document is current

Article History

Received: 12 December 2025

Accepted: 3 February 2026

First Online: 27 February 2026

Declarations

:

: The training needs and assessment survey “NeoIPC-IMPLEMENT—Preconditions for implementing infection prevention interventions in neonatal intensive care” used in the feasibility study preceeding NeoIPC has been exempt from review (Req-2022–00263) by the Ethics Committee of the Canton of Zurich. Ethical clearance for the NeoDeco study was obtained from the local and institutional review boards from Ethikkommission Nordwest- und Zentralschweiz (EKNZ), Switzerland; Ethics committee of Attikon General Hospital, Greece; Ethics committee of Aglaia Kyriakou Children's Hospital, Greece; Ethics committee of Hippokration Hospital, Greece; Ethics committee of Ioannina University Hospital, Greece; Ethics committee of Papageorgiou Hospital, Greece; Ethics committee of University Hospital of Heraklion, Greece; Ethics committee of University General Hospital of Patras, Greece; Comitato Etico Area Vasta Emilia Nord, Italy; Comitato Etico Locale Palermo I, Italy; Comitato Etico Area Vasta Emilia Centro, Italy; Comitato Etico Territoriale Area Sud Ovest Veneto, Italy; Comitè de Etica de la Investigaciòn con medicamentos de Euskadi, Spain; Comitè de Etica para la Investigaciòn con medicamentos del Departamento de salud de Alicante -Hospital General; Comitè de Etica de la Investigaciòn con medicamentos Provincial de Malaga, Spain; NHS Health Research Authority, United Kingdom.

: Not applicable.

: CHvW reports research funding from bioMérieux, Davolterra, MSD Europe and LimmaTech via institution. Other authors declare that they have no competing interests.